Moreover, genetic knockout (Hook et al., 2009; Kindy et al., 2012) and chemical inhibition (Hook et al., 2008; Cho et al., 2013) studies in cellular and animal models of AD have demonstrated that inhibiting cathepsin B reduces Aβ burden and improves cognitive function. Here, CTSB is linked to Alzheimer disease.